Filing Flows › Cue Biopharma (CUE) › Q2 2026 › vs Q1 2026
Cue Biopharma (CUE) Q2 2026 vs Q1 2026 (quarter over quarter)
Cue Biopharma's revenue rose $2.2M (+39%) from $5.7M in Q1 2026 to $7.9M in Q2 2026.
Cue Biopharma, Q2 2026: revenue $7.9M (+167% year over year), net loss $153M, operating cash flow −$29.0M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $7.9M | $5.7M | $2.2M | +39% |
| Net loss | $153M | $5.2M | $148M | 30× |
| Costs & expenses | $161M | $11.0M | $150M | 15× |
| Operating costs | $95.6M | $11.0M | $84.5M | +766% |
| Interest & other, net | $65.4M | −$175K | $65.5M | — |
| Research & development | $49.0M | $6.9M | $42.1M | +611% |
| General & admin | $46.6M | $4.2M | $42.4M | 11× |
| Operating cash sources | $153M | $5.2M | $148M | 30× |
| Depreciation & amortization | $36K | $566K | −$530K | -94% |
| Share-based compensation | $23.8M | $48K | $23.8M | 497× |
| Working capital & other | $100M | −$6.4M | $107M | — |
| Cash used in operations | $29.0M | $10.9M | $18.1M | +165% |
| Net loss absorbed | $153M | $5.2M | $148M | 30× |
Questions
How much did Cue Biopharma's revenue grow quarter over quarter in Q2 2026?
Cue Biopharma's revenue rose $2.2M (+39%) from $5.7M in Q1 2026 to $7.9M in Q2 2026.